Sclerosis of lytic metastatic bone lesions during treatment with pamidronate in a patient with adenocarcinoma of unknown primary site

1996 ◽  
Vol 5 (3) ◽  
pp. 198-200 ◽  
Author(s):  
M. Tanaka ◽  
H. Fushimi ◽  
T. Fuji ◽  
J. M. Ford
Keyword(s):  
Primary Site ◽  
Unknown Primary ◽  
Bone Lesions ◽  
Unknown Primary Site

Metastatic neuroendocrine tumor of unknown primary site with associated carcinoid syndrome in a young patient–a case report

2020 ◽  
Author(s):  
Sima Antonia ◽  
Florentina Burcea Iulia ◽  
Cristina Sorohan Mădălina ◽  
Dușceac Roxana ◽  
Poiană Cătălina
Keyword(s):  
Case Report ◽  
Neuroendocrine Tumor ◽  
Young Patient ◽  
Carcinoid Syndrome ◽  
Primary Site ◽  
Unknown Primary ◽  
Unknown Primary Site ◽  
Metastatic Neuroendocrine Tumor

scholarly journals Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site

2021 ◽  
Author(s):  
Xinrong Li ◽  
Yan Shao ◽  
Liqiang Sheng ◽  
Junquan Zhu ◽  
Zeming Wang ◽  
...  
Keyword(s):  
Risk Factors ◽  
Primary Site ◽  
Unknown Primary ◽  
Tumor Site ◽  
Metastatic Adenocarcinoma ◽  
Unknown Primary Site

scholarly journals Baseline Staging of Melanoma with Unknown Primary Site: The Value of Serum S100 Protein and Positron Emission Tomography

Dermatology ◽  
2008 ◽  
Vol 217 (4) ◽  
pp. 351-355 ◽  
Author(s):  
Patrick A. Oberholzer ◽  
Mirjana Urosevic ◽  
Hans C. Steinert ◽  
Reinhard Dummer
Keyword(s):  
Positron Emission Tomography ◽  
S100 Protein ◽  
Primary Site ◽  
Emission Tomography ◽  
Unknown Primary ◽  
Unknown Primary Site ◽  
Positron Emission ◽  
Baseline Staging

scholarly journals Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site

JAMA Oncology ◽  
2015 ◽  
Vol 1 (1) ◽  
pp. 40 ◽  
Author(s):  
Jeffrey S. Ross ◽  
Kai Wang ◽  
Laurie Gay ◽  
Geoff A. Otto ◽  
Emily White ◽  
...  
Keyword(s):  
Primary Site ◽  
Unknown Primary ◽  
Genomic Profiling ◽  
Unknown Primary Site ◽  
Carcinoma Of Unknown Primary ◽  
Comprehensive Genomic Profiling

Tongue base mucosectomy for carcinoma of unknown primary using endoscopic electrocautery: rationale for wider implementation of an institutionally restricted technique

2018 ◽  
Vol 132 (12) ◽  
pp. 1138-1142 ◽  
Author(s):  
C R Davies-Husband
Keyword(s):  
Primary Tumour ◽  
Intensity Modulated Radiotherapy ◽  
Cervical Squamous Cell Carcinoma ◽  
Primary Site ◽  
Tongue Base ◽  
Unknown Primary ◽  
Unknown Primary Site ◽  
Cervical Metastasis ◽  
Positron Emission ◽  
Negative Findings

AbstractBackgroundCervical metastasis from an unknown primary site invariably results in pan-mucosal irradiation if a primary tumour is not identified. Transoral robotic and laser-assisted mucosectomy are valid techniques to increase diagnostic rates, but these remain restricted to certain centres. This paper describes, in detail, a technique in which mucosectomy is performed via endoscopic electrocautery.MethodsPatients were prospectively recruited between May 2017 and June 2018. Inclusion criteria stipulated biopsy-proven metastatic cervical squamous cell carcinoma, with negative findings on magnetic resonance imaging and positron emission tomography/computed tomography, in addition to examination under anaesthetic, tonsillectomy and ‘blind’ tongue base biopsies without tumour identification, prior to mucosectomy.ResultsOf nine patients, a mucosal primary was identified in four (44.4 per cent), for which ipsilateral intensity-modulated radiotherapy was advocated in three and completion tongue base resection in the fourth. Dysplasia was demonstrated in two further patients, which provided information relevant to radiotherapy fields and post-treatment surveillance. No surgical complications were identified.ConclusionTongue base mucosectomy using electrocautery and conventional tonsillectomy equipment is a safe, effective technique in the identification of cervical metastasis from an unknown primary site. It expands the potential breadth of use, quickens prolonged diagnostic pathways and obviates the necessity for pan-mucosal irradiation.

Carcinoma of Unknown Primary Site a Complete and Sustained Response with Interleukin-2, alpha Interferon and 5 Fluorouracil/Leucovorin

1992 ◽  
Vol 31 (5) ◽  
pp. 592-593
Author(s):  
Harish P. G. Dave ◽  
Chiristine I. White ◽  
Richard Schulof ◽  
Frederick P. Avis
Keyword(s):  
Interleukin 2 ◽  
Primary Site ◽  
Sustained Response ◽  
Alpha Interferon ◽  
Unknown Primary ◽  
Unknown Primary Site ◽  
Carcinoma Of Unknown Primary
Sign in / Sign up

Export Citation Format

Share Document